Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Back in this, this is a Buy and Hold now.
Its going to go alot higher in the coming days.
cheers,
moe.
more details please...
cheers,
moe.
This is why you got to get in and out quickly and watch these things like a hawk. I was able to get out at .96 this second round but wish I would have pulled the trigger earlier at 1.03. But hey can't complain.
Have a feeling it'll go higher in due time when the sale actually happens but needs to consolidate a bit right now.
Hopefully everyone made money on this. If you bought at any point yesterday, you're still up.
cheers,
moe.
Jumped back in, buy pressure is too strong, this is going to break a dollar today.
cheers,
moe.
great trade! In at .55, out at .78. Plenty of liquiduty, $8k in 24 hours.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124980168
cheers,
moe.
Tuning into the conference call, he said that with this deal they will pay off their debt and have no shortage of capital going forward.
NAVB .55 +60% nyse stock! $80 Mill Buyout news! 4 times the average volume already, Going alot higher imo!
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek(R) in North America
6:59 AM ET 9/6/16 | BusinessWire
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that it has executed a Letter of Intent ("LOI") with Cardinal Health, Inc. (NYSE:CAH) for the sale of all rights, title and interest to Navidea's Lymphoseek product for all FDA-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million.
As part of the transaction, Cardinal Health would license back to Navidea a portion of the acquired intellectual property such that Navidea will be able to develop, manufacture, market, sell and distribute new products that do not in any way compete with the current Lymphoseek product, and to continue to manufacture, market, sell and distribute Lymphoseek outside of North America.
Michael M. Goldberg, M.D., Chairman of the Board of Directors, Navidea Biopharmaceuticals, said "This is a significant announcement for all of us at Navidea. This agreement with Cardinal Health will provide significant financial resources for us to repay all outstanding debt to CRG and accelerate the development of our robust pipeline of diagnostic products, which are notably focused on Rheumatoid Arthritis and Cardiovascular disease, as well as our Macrophage Therapeutics pipeline. We have enjoyed a longstanding and successful relationship with Cardinal Health, and we are looking forward to continuing our collaboration."
"Lymphoseek has been an important diagnostic tool for physicians and their patients who are looking for additional clarity when facing potentially life-changing diagnoses," said Tiffany Olson, President of Nuclear Pharmacy Services for Cardinal Health. "We have been Navidea's exclusive US distributor of Lymphoseek for many years. That relationship has set the groundwork for this new agreement, and the Cardinal Health team will continue to market, sell and provide Lymphoseek to those who need it."
The closing of this transaction is subject to the completion of due diligence and the negotiation of definitive documents, among other things, and is dependent upon customary approvals.
Navidea will hold a webcast conference call with investors on Wednesday, September 7, 2016 at 8:30 am ET. Details of the call will be issued later today and will be posted on the Company's Investor website.
NAVB .55 +60% nyse stock! $80 Mill Buyout news! 4 times the average volume already, Going alot higher imo!
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek(R) in North America
6:59 AM ET 9/6/16 | BusinessWire
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that it has executed a Letter of Intent ("LOI") with Cardinal Health, Inc. (NYSE:CAH) for the sale of all rights, title and interest to Navidea's Lymphoseek product for all FDA-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million.
As part of the transaction, Cardinal Health would license back to Navidea a portion of the acquired intellectual property such that Navidea will be able to develop, manufacture, market, sell and distribute new products that do not in any way compete with the current Lymphoseek product, and to continue to manufacture, market, sell and distribute Lymphoseek outside of North America.
Michael M. Goldberg, M.D., Chairman of the Board of Directors, Navidea Biopharmaceuticals, said "This is a significant announcement for all of us at Navidea. This agreement with Cardinal Health will provide significant financial resources for us to repay all outstanding debt to CRG and accelerate the development of our robust pipeline of diagnostic products, which are notably focused on Rheumatoid Arthritis and Cardiovascular disease, as well as our Macrophage Therapeutics pipeline. We have enjoyed a longstanding and successful relationship with Cardinal Health, and we are looking forward to continuing our collaboration."
"Lymphoseek has been an important diagnostic tool for physicians and their patients who are looking for additional clarity when facing potentially life-changing diagnoses," said Tiffany Olson, President of Nuclear Pharmacy Services for Cardinal Health. "We have been Navidea's exclusive US distributor of Lymphoseek for many years. That relationship has set the groundwork for this new agreement, and the Cardinal Health team will continue to market, sell and provide Lymphoseek to those who need it."
The closing of this transaction is subject to the completion of due diligence and the negotiation of definitive documents, among other things, and is dependent upon customary approvals.
Navidea will hold a webcast conference call with investors on Wednesday, September 7, 2016 at 8:30 am ET. Details of the call will be issued later today and will be posted on the Company's Investor website.
Mindless cheerleading here, are you sure now that I wont be able to get back in? LOL
cheers,
moe.
In at .021 yesterday, Out at .0255. Good trade!
cheers,
moe.
Good entry point, this has been consolidating for 2 weeks.
cheers,
moe.
Volcano Exploding Up!
SUPER VOLCANO COMING
stick with that lol
Its in the green and nearing a new 52 week high ....
If you want to see "Tanking on big volume", take a look at F P V D.
cheers,
moe.
ummm sureeeee, good luck to you too lol
If you are scared of certain MMs who you think only dilute then you basically should stay away from all penny stocks as they are is one all of them regardless of what they are doing.
This is pure consolidation. No other way to put it.
cheers,
moe.
Not tanking here, still way higher than where it opened yesterday, volume will come as the news spreads.
Funny how you weren't yesterday or the day before to warn all of us. lol go figure
cheers,
moe.
Sure doesn't look like dilution to me, but if you want to scare people out of their shares then go ahead.
Just basic consolidation here getting ready for the next leg...stocks 101.
If you want to see company dumping shares then look at F P V D.
cheers,
moe.
200 million A/S 153 million O/S
Pretty low Share Structure.
cheers,
moe.
Mindless pumping all over ihub more than ever. This isn't 2006 folks, ppl are wiser with their money.
cheers,
moe.
TRON Reverse Split Pending
Isn't there a reverse split coming right around the corner?
cheers,
moe.
Lets try to get to half a penny first
cheers,
moe.
Can someone post level II please?
cheers,
moe.
lol slow down there cowboy, chances are commons will be wiped dry if Vista buys them just like they did with WTSL earlier this year.
Pure momo play at the moment imo.
cheers,
moe.
EX CFO...
this has already been discussed...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119139360
cheers,
moe.
That had to be a MMs way of trying to either cover or grab shares. Fist they take it down to .0009 at the open, now after no ones whacking into the bid, they're raising it back up to where it was on small ask hits. I highly doubt anyone is paying $10 on a $1 trade.
On the plus side, the bid looks strong and the spread is the tightest I have seen in a while here. Setting up for a major move here imo.
cheers,
moe.
Good loading zone here, I've been adding where ever I can. Bought some yesterday and last week. I've been averaging up and I consider that a good thing. The 3 month chart looks great, definitely trending higher.
Lets hope we get some more news this week. Glad the CEO mentioned more details are coming and to hang tight! He hasn't let us down yet imo!
cheers,
moe.
man I think he is on the wrong board.
cheers,
moe.
Higher lows are here, hopefully higher highs soon too!
cheers,
moe.
Only ~$800 on the ask.
cheers,
moe.
I suppose, at this point, everyone is just waiting for more news.
cheers,
moe.
Apparently the other company must have a lot of butthurt shareholders, their hanging onto anything now. lol
GOO RSII, hoping for a not so quiet week here!
cheers,
moe.
Looks to me like this asset purchase is just that as stated in the recent PR, a purchase of some of their assets. NOT their liabilities. I'm not sure why the other company is being brought up so much, RSII has no obligation to any other shareholders but their own. If someone is curious about anything relating to the other company, then perhaps they should be on that board and emailing that CEO.
Likewise, any comments made related to any other ticker will be reported for TOS violation.
cheers,
moe.
It's about to get good in here, they keep giving more reasons to buy. Just a matter of time before RSII breaks out of this range.
Cheers,
Moe.
Bad move imo
cheers,
moe.
It went down to .0002 very very shortly, I think only a few shares were grabbed at that time. That was also before any filings were out. After the filings came this started churning for 2 months in the trips and there weren't really much shares there.
On a side note, man you have been here for a while you should have just bought a few lol. Happy holidays though I wish you all the best.
cheers,
moe.
Good loading zone right here, chart is setting up nicely. Easy 1st push to .003s coming soon imo.
cheers,
moe.
Atleast we got a boost in volume and posts today.
cheers,
moe.
52 week high is .0021! blue skies after that.
cheers,
moe.